Defective Cell Cycle Checkpoint Functions in Melanoma Are Associated with Altered Patterns of Gene Expression
Open accessThe DOI matches its Crossref record; 68 of the 70 references it cites were found in a registry or an index.
Abstract
Defects in DNA damage responses may underlie genetic instability and malignant progression in melanoma. Cultures of normal human melanocytes (NHMs) and melanoma lines were analyzed to determine whether global patterns of gene expression could predict the efficacy of DNA damage cell cycle checkpoints that arrest growth and suppress genetic instability. NHMs displayed effective G1 and G2 checkpoint responses to ionizing radiation-induced DNA damage. A majority of melanoma cell lines (11/16) displayed significant quantitative defects in one or both checkpoints. Melanomas with B-RAF mutations as a class displayed a significant defect in DNA damage G2 checkpoint function. In contrast the epithelial-like subtype of melanomas with wild-type N-RAS and B-RAF alleles displayed an effective G2 checkpoint but a significant defect in G1 checkpoint function. RNA expression profiling revealed that melanoma lines with defects in the DNA damage G1 checkpoint displayed reduced expression of p53 transcriptional targets, such as CDKN1A and DDB2, and enhanced expression of proliferation-associated genes, such as CDC7 and GEMININ. A Bayesian analysis tool was more accurate than significance analysis of microarrays for predicting checkpoint function using a leave-one-out method. The results suggest that defects in DNA damage checkpoints may be recognized in melanomas through analysis of gene expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While several studies found an association between DNA damage response gene upregulation and melanoma progression, the upregulated genes did not include NER genes64,65.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [64]
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Diagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R., Hastie, T., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,930
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836 · cited 2×
“Alterations in the p53 signaling pathway could contribute to melanoma genesis through attenuation of DNA repair, cell cycle checkpoint function, or apoptosis (Kastan and Bartek, 2004), leading to enhanced mutation and reduced cell death.”
BackgroundDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 6×
“Normal cell proliferation, as induced by growth factors in medium, did not cause DNA damage, suggesting that the disregulated S phase was responsible (Bartkova et al., 2005).”
BackgroundInfluentialMegabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo
Rogakou, E. P., Boon, C., Redon, C., & Bonner, W. M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.905 · Cited by 2,422
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 2×
“Expression of oncogenic B-RAF in normal melanocytes induces growth arrest through induction of p16 (Michaloglou et al., 2005; Gray-Schopfer et al., 2006).”
BackgroundActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 2×
“This condition of enhanced DNA damage and activation of the DNA damage response was induced in normal human fibroblasts by expression of gene products such as CDC6, cyclin E, and E2F1 that drive cells into a precocious S phase and by activated oncogenes, including H-RAS (Bartkova et al., 2005, 2006; Di Micco et al., 2…”
BackgroundOncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 1×
“…DNA damage and activation of the DNA damage response was induced in normal human fibroblasts by expression of gene products such as CDC6, cyclin E, and E2F1 that drive cells into a precocious S phase and by activated oncogenes, including H-RAS (Bartkova et al., 2005, 2006; Di Micco et al., 2006).”
BackgroundPeng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341 · cited 2×
“Other potential targets for attenuation of G2 checkpoint function are 14-3-3 proteins and Cdc25C (Peng et al., 1997).”
BackgroundThe pathogenesis of melanoma induced by ultraviolet radiation
Gilchrest, B. A., Eller, M. S., Geller, A. C., & Yaar, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401707 · Cited by 876
Induction of WAF1/CIP1 by a p53-independent pathway.
Michieli, P., Chedid, M., Lin, D. P., Pierce, J. H., Mercer, W. E., & Givol, D. (1994) · PubMed · Cited by 768
Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks
Bekker-Jensen, S., Lukas, C., Kitagawa, R., Melander, F., Kastan, M. B., Bartek, J., & Lukas, J. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200510130 · Cited by 625
Detecting differential gene expression with a semiparametric hierarchical mixture method
Newton, M. A. (2004) · Biostatistics · doi:10.1093/biostatistics/5.2.155 · Cited by 564
Genetic Interaction Between NRAS and BRAF Mutations and PTEN/MMAC1 Inactivation in Melanoma
Tsao, H., Yang, G., Goel, V., Wu, H., & Haluska, F. G. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22243.x · Cited by 467
Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas
Hoek, K., Rimm, D. L., Williams, K. R., Zhao, H., Ariyan, S., Lin, A., Kluger, H. M., Berger, A. J., Cheng, E., Trombetta, E. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0731 · Cited by 448
Satyamoorthy, K., Li, G., Gerrero, M. R., Brose, M. S., Volpe, P., Weber, B. L., Belle, P. A. V., Elder, D. E., & Herlyn, M. (2003) · PubMed · Cited by 445
The gene expression signatures of melanoma progression
Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B. L., Federman, S., Miller, J. R., Allen, R. E., Singer, M. I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501564102 · Cited by 433
Expression profiling reveals novel pathways in the transformation of Melanocytes to Melanomas.
Hoek, K., Rimm, D., Williams, K., Zhao, H., Ariyan, S., Lin, A., Kluger, H., Berger, A., Cheng, E., Trombetta, E. S., et al. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00175_12.x · Cited by 412
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
Gray-Schopfer, V. C., Cheong, S. C., Chong, H., Chow, J., Moss, T., Abdel-Malek, Z. A., Marais, R., Wynford-Thomas, D., & Bennett, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603283 · Cited by 394
Lack of PTEN sequesters CHK1 and initiates genetic instability
Puc, J., Keniry, M., Li, H. S., Pandita, T. K., Choudhury, A. D., Memeo, L., Mansukhani, M., Murty, V. V. V. S., Gaciong, Z., Meek, S. E. M., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.009 · Cited by 328
Lifetime Risks of Common Cancers Among Retinoblastoma Survivors
Fletcher, O., Easton, D., Anderson, K., Gilham, C., Jay, M., & Peto, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh058 · Cited by 312
TP53 mutations in human skin cancers
Giglia-Mari, G., & Sarasin, A. (2003) · Human Mutation · doi:10.1002/humu.10179 · Cited by 292
Towards a novel classification of human malignancies based on gene expression patterns
Alizadeh, A. A., Ross, D. T., Perou, C. M., & van de Rijn, M. (2001) · The Journal of Pathology · doi:10.1002/path.889 · Cited by 280
Brown, A. L., Lee, C.-H., Schwarz, J. K., Mitiku, N., Piwnica-Worms, H., & Chung, J. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3745 · Cited by 261
Heffernan, T. P., Simpson, D. A., Frank, A. R., Heinloth, A. N., Paules, R. S., Cordeiro-Stone, M., & Kaufmann, W. K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8552-8561.2002 · Cited by 251
Self-citationProgression in Cutaneous Malignant Melanoma Is Associated with Distinct Expression Profiles
Alonso, S. R., Ortiz, P., Pollán, M., Pérez-Gómez, B., Sánchez, L., Acuña, M. J., Pajares, R., Martínez-Tello, F. J., Hortelano, C. M., Piris, M. A., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63110-0 · Cited by 244
Kumar, R., Angelini, S., Snellman, E., & Hemminki, K. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22225.x · Cited by 229
Zampetti-Bosseler, F., & Scott, D. (1981) · International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine · doi:10.1080/09553008114550651 · Cited by 219
BRAF alterations are associated with complex mutational profiles in malignant melanoma
Daniotti, M., Oggionni, M., Ranzani, T., Vallacchi, V., Campi, V., Di Stasi, D., Torre, G. D., Perrone, F., Luoni, C., Suardi, S., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207780 · Cited by 210
Bauer, J., & Bastian, B. C. (2006) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2005.00055.x · Cited by 204
Use of human tissue to assess the oncogenic activity of melanoma-associated mutations
Chudnovsky, Y., Adams, A. E., Robbins, P. B., Lin, Q., & Khavari, P. A. (2005) · Nature Genetics · doi:10.1038/ng1586 · Cited by 198
Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma
Thomas, N. E., Edmiston, S. N., Alexander, A., Millikan, R. C., Groben, P. A., Hao, H., Tolbert, D., Berwick, M., Busam, K., Begg, C. B., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-1038 · Cited by 192
Self-citationMelanoma Incidence and Mortality Among US Whites, 1969-1999
Geller, A. C. (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.14.1719 · Cited by 192
Demers, G. W., Foster, S. A., Halbert, C. L., & Galloway, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4382 · Cited by 172
Defective G2 checkpoint function in cells from individuals with familial cancer syndromes.
Paules, R. S., Levedakou, E. N., Wilson, S. J., Innes, C. L., Rhodes, N., Tlsty, T. D., Galloway, D. A., Donehower, L. A., Tainsky, M. A., & Kaufmann, W. K. (1995) · PubMed · Cited by 169
Self-citationGene expression patterns associated with p53 status in breast cancer
Troester, M. A., Herschkowitz, J. I., Oh, D. S., He, X., Hoadley, K. A., Barbier, C. S., & Perou, C. M. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-276 · Cited by 168
Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines
Bloethner, S., Chen, B., Hemminki, K., Müller-Berghaus, J., Ugurel, S., Schadendorf, D., & Kumar, R. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi066 · Cited by 138
Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma
Pho, L. N., Grossman, D., & Leachman, S. A. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000208791.22442.09 · Cited by 125
Caffeine and human DNA metabolism: the magic and the mystery
Kaufmann, W. K., Heffernan, T. P., Beaulieu, L. M., Doherty, S., Frank, A. R., Zhou, Y., Bryant, M. F., Zhou, T., Luche, D. D., Nikolaishvili-Feinberg, N., et al. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.08.012 · Cited by 114
Self-citationAberrant regulation and function of wild-type p53 in radioresistant melanoma cells.
Satyamoorthy, K., Chehab, N. H., Waterman, M. J. F., Lien, M. C., El‐Deiry, W. S., Herlyn, M., & Halazonetis, T. D. (2000) · PubMed · Cited by 114
Wang, Q.-E., Zhu, Q., Wani, G., Chen, J., & Wani, A. A. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh085 · Cited by 104 · cited 1×
“DDB2 encodes a factor that appears to aid in recruitment of other repair factors to sites of damaged DNA in chromatin (Wang et al., 2004).”
BackgroundItoh, T., Cado, D., Kamide, R., & Linn, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306551101 · Cited by 98
The risk of developing second cancers among survivors of childhood soft tissue sarcoma
Cohen, R. J., Curtis, R. E., Inskip, P. D., & Fraumeni, J. F. (2005) · Cancer · doi:10.1002/cncr.21040 · Cited by 93
Knauf, J. A., Ouyang, B., Knudsen, E. S., Fukasawa, K., Babcock, G., & Fagin, J. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511690200 · Cited by 92
Itoh, T., O’Shea, C. E., & Linn, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7540-7553.2003 · Cited by 84
Frequency of UV-Inducible NRAS Mutations in Melanomas of Patients With Germline CDKN2A Mutations
Eskandarpour, M., Hashemi, J., Kanter, L., Ringborg, U., Platz, A., & Hansson, J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.11.790 · Cited by 83
Effects of PGF2α on human melanocytes and regulation of the FP receptor by ultraviolet radiation
SCOTT, G. A., Jacobs, S. E., Leopardi, S., Anthony, F. A., Learn, D., Malaviya, R., & Pentland, A. P. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.11.016 · Cited by 81
Self-citationShields, J. M., Thomas, N. E., Cregger, M., Berger, A. J., Leslie, M., Torrice, C., Hao, H., Penland, S., Arbiser, J., Scott, G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3311 · Cited by 81
Self-citationMelanoma Cells Express Elevated Levels of Phosphorylated Histone H2AX Foci
Warters, R. L., Adamson, P. J., Pond, C. D., & Leachman, S. A. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23674.x · Cited by 73
Cell Cycle Checkpoint Function in Bladder Cancer
Doherty, S. C., McKeown, S. R., McKelvey-Martin, V., Downes, C. S., Atala, A., Yoo, J. J., Simpson, D. A., & Kaufmann, W. K. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg120 · Cited by 73
Self-citationBiallelic Deletions in INK4 in Cutaneous Melanoma Are Common and Associated with Decreased Survival
Grafström, E., Egyházi, S., Ringborg, U., Hansson, J., & Platz, A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1731 · Cited by 61
Gene Expression Profiling of Melanocytic Lesions
Seykora, J. T., Jih, D., Elenitsas, R., Horng, W.-H., & Elder, D. E. (2003) · American Journal of Dermatopathology · doi:10.1097/00000372-200302000-00002 · Cited by 60
Functional Analysis of the p53 Pathway in Response to Ionizing Radiation in Uveal Melanoma
Sun, Y., Tran, B. N., Worley, L. A., Delston, R. B., & Harbour, J. W. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1362 · Cited by 57
Tandem BRAF Mutations in Primary Invasive Melanomas
Thomas, N. E., Alexander, A., Edmiston, S. N., Parrish, E., Millikan, R. C., Berwick, M., Groben, P., Ollila, D. W., Mattingly, D., & Conway, K. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22523.x · Cited by 57
Self-citationG1 arrest cell-cycle-dependent clastogenesis in UV-irradiated human fibroblasts
Kaufmann, W. K., & Wilson, S. J. (1994) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(94)90062-0 · Cited by 56
Self-citationSignaling Networks in Cutaneous Melanoma Metastasis Identified by Complementary DNA Microarrays
Nambiar, S., Mirmohammadsadegh, A., Doroudi, R., Gustrau, A., Marini, A., Roeder, G., Ruzicka, T., & Hengge, U. R. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.2.165 · Cited by 48
Reduced DNA Repair in Cultured Melanocytes and Nevus Cells From a Patient With Xeroderma Pigmentosum
Kraemer, K. H. (1989) · Archives of Dermatology · doi:10.1001/archderm.125.2.263 · Cited by 39
Marrot, L., Belaïdi, J.-P., Jones, C., Perez, P., & Meunier, J.-R. (2004) · Photochemistry and Photobiology · doi:10.1562/2004-10-13-ra-343 · Cited by 37
The Genes and Genetics of Malignant Melanoma
Gibbs, P., Brady, B., & Robinson, W. A. (2002) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/s10227-001-0037-6 · Cited by 24
Activation of Ras-Ral Pathway Attenuates p53-independent DNA Damage G2 Checkpoint
Agapova, L. S., Volodina, Y. L., Chumakov, P. M., & Kopnin, B. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405007200 · Cited by 23
Kaufmann, W. K., Campbell, C. B., Simpson, D. A., Deming, P. B., Filatov, L. V., Galloway, D. A., Zhao, X. J., Creighton, A. M., & Downes, C. S. (2002) · Cell Cycle · doi:10.4161/cc.1.3.127 · Cited by 20
Self-citationSmalley, K. S. M., & Herlyn, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23430.x · Cited by 20
Marrot, L., Belaïdi, J.-P., Jones, C., Perez, P., & Meunier, J.-R. (2005) · Photochemistry and Photobiology · doi:10.1562/2004-10-13-ra-343.1 · Cited by 19
Simpson, D. A., Livanos, E., Heffernan, T. P., & Kaufmann, W. K. (2005) · Journal of Carcinogenesis · doi:10.1186/1477-3163-4-18 · Cited by 17
Self-citationOncogenic H-ras induces cyclin B1 expression in a p53-independent manner
Santana, C., Ortega, E., & García-Carrancá, A. M. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00172-0 · Cited by 16
Noonan, D. M., Severino, A., Morini, M., Tritarelli, A., Manente, L., D’Agnano, I., Starace, G., Baldi, A., Lombardi, D., Albini, A., et al. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20182 · Cited by 11
Cited by
Mechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
Roles of UVA radiation and DNA damage responses in melanoma pathogenesis
Khan, A. Q., Travers, J. B., & Kemp, M. G. (2018) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22176 · Cited by 152
“Inter- estingly, a majority of melanoma cell lines were found to display defects in one or both checkpoints following exposure to ionizing radiation [Kaufmann et al., 2008; Carson et al., 2012].”
BackgroundBonte, D., Lindvall, C., Liu, H., Dykema, K., Furge, K., & Weinreich, M. (2008) · Neoplasia · doi:10.1593/neo.08216 · Cited by 133
Scott, M. C., Sarver, A. L., Gavin, K. J., Thayanithy, V., Getzy, D. M., Newman, R. A., Cutter, G. R., Lindblad-Toh, K., Kisseberth, W. C., Hunter, L. E., et al. (2011) · Bone · doi:10.1016/j.bone.2011.05.008 · Cited by 121
Pal, H. C., Sharma, S., Strickland, L. R., Katiyar, S. K., Ballestas, M. E., Athar, M., Elmets, C. A., & Afaq, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086338 · Cited by 113
Metadata
- Authors
- Kaufmann, W. K., Nevis, K. R., Qu, P., Ibrahim, J. G., Zhou, T., Zhou, Y., Simpson, D. A., Helms-Deaton, J., Cordeiro-Stone, M., Moore, D. T., Thomas, N. E., Hao, H., Liu, Z., Shields, J. M., Scott, G. A., & Sharpless, N. E.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- University of Rochester Medicine (US)
- Corresponding author
- Kaufmann, William K.
- ORCID
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 128
- Issue
- 1
- Pages
- 175-187
- ISSN
- 0022-202X (ISSN-L)
- PMC
- PMC2753794
- OpenAlex
- W1981058260
- Cited by
- 65
- References
- 70
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 5 · 2013: 7 · 2012: 5
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2892 d)
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Cancer Institute (CA-160-86, R01CA112243, T32CA106209, P30CA016086)
- National Institute of General Medical Sciences (R01GM070335)
- National Institute of Environmental Health Sciences (ES07017, U19ES011391, ES-11391, ES 10126, T32ES007017, P30ES010126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- melanoma, DNA damage response, cell cycle checkpoints, G1/S checkpoint, G2 checkpoint, genomic instability, BRAF mutation, NRAS, p21, DDB2, CDC7, geminin, gene expression profiling, ionizing radiation, melanocytes, Bayesian analysis, significance analysis of microarrays
- MeSH terms
- Cells, Cultured, DNA Damage, DNA-Binding Proteins, Humans, Melanocytes, Melanoma, Mutation, Phosphorylation, Tumor Suppressor Protein p53, G1 Phase, G2 Phase, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Gene Expression Profiling, Chromosomal Instability, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, Cyclin-Dependent Kinase Inhibitor p21, DNA Breaks, Double-Stranded, Geminin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.